Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis

Tolou-Ghamari, Zahra; Shygannejad, Vahid; Ashtari, Fereshteh; Chitsaz, Ahmad; Palizban, Abbas Ali

Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis

Authors

¹ Isfahan Neurosciences Research Centre, Alzahra Hospital, Isfahan, Iran

² Isfahan Neurosciences Research Centre, Alzahra Hospital; Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Clinical Biochemistry, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Previous publications reported that an individual's month of birth (MOB) might have an important correlation to that consequent risk of multiple sclerosis (MS).
Aim: The aim of this preliminary study was to investigate the distribution of different MOBs inpatients with MS in Isfahan, Iran.
Materials and Methods: This investigation was conducted to the Isfahan Neurosciences Research Centre. 1283 patients with MS were studied. Clinical data were recorded in d-Base and analyzed using SPSS (version 18) for Windows.
Results: Of the total population studied there were 979 females and 304 males. The mean age of all the patients was 34.6 years (range 10-87 years). Within the total population, the MOBs in the 62% of patients were in the season's spring and summer, and in 38% of patients they were in the season's autumn and winter. As the MOB might be recognized to have a bearing on an individual's risk of contracting MS, the highest and lowest correlations seem to be linked with April, September, May (↑), and November (↓), respectively.
Conclusions: The seasonal relationship between MOBs and MS risk might be pointed toward a potential function for vitamin D throughout pregnancy or the early life of the newborn. Further studies are needed to confirm these correlations.

Keywords

References

1.	Bradford CM, Ramos I, Cross AK, Haddock G, McQuaid S, Nicholas AP, et al. Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis. J Neuroimmunol 2014;273:85-95.
2.	Shaygannejad V, Tolou-Ghamari Z. What is the real fate of vitamin D in multiple sclerosis? Int J Prev Med 2013;4(Suppl 2):S159-64.
3.	Tolou-Ghamari Z, Shaygannejad V, Ashtari F. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the Isfahan Kashani Hospital. Int J Prev Med 2013;4(Suppl 2):S274-8.
4.	Torkildsen O, Grytten N, Aarseth J, Myhr KM, Kampman MT. Month of birth as a risk factor for multiple sclerosis: An update. Acta Neurol Scand Suppl 2012;58-62.
5.	Disanto G, Chaplin G, Morahan JM, Giovannoni G, Hyppönen E, Ebers GC, et al. Month of birth, vitamin D and risk of immune-mediated disease: A case control study. BMC Med 2012;10:69.
6.	Saastamoinen KP, Auvinen MK, Tienari PJ. Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland. Mult Scler 2012;18:563-8.
7.	Nikseresht A, Sharifian M, Hamidian Jahromi A. Month of birth and the incidence of multiple sclerosis in southern Iran. Iran J Med Sci 2014;39(Suppl):232-3.
8.	Fiddes B, Wason J, Kemppinen A, Ban M, Compston A, Sawcer S. Confounding underlies the apparent month of birth effect in multiple sclerosis. Ann Neurol 2013;73:714-20.
9.	Sá MJ. Month of birth is not a definite risk factor for multiple sclerosis. Arq Neuropsiquiatr 2014;72:397.
10.	Fragoso YD, Adoni T, Almeida SM, Alves-Leon SV, Arruda WO, Barbagelata-Aguero F, et al. Multiple sclerosis in South America: Month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease. Arq Neuropsiquiatr 2013;71:573-9.
11.	Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: A systematic review. Eur Neurol 2013;70:356-63.
12.	Etemadifar M, Abtahi SH. Multiple sclerosis in Isfahan, Iran: Past, Present and Future. Int J Prev Med 2012;3:301-2. [PUBMED]
13.	Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006;27:39-44.
14.	Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis Isfahan, Iran. Mult Scler 2011;17:1022-7.
15.	Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry 2013;84:427-32.
16.	Kezuka T. Optic neuritis- Immunological approach to elucidate pathogenesis and develop innovative therapy. Nihon Ganka Gakkai Zasshi 2013;117:270-92.
17.	Oreja-Guevara C, González-Segura D, Vila C. Spasticity in multiple sclerosis: Results of a patient survey. Int J Neurosci 2013;123:400-8.
18.	Hecker M, Hartmann C, Kandulski O, Paap BK, Koczan D, Thiesen HJ, et al. Interferon-beta therapy in multiple sclerosis: The short-term and long-term effects on the patients' individual gene expression in peripheral blood. Mol Neurobiol 2013;48:737-56.
19.	Ohji S, Nomura K. The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis. Nihon Rinsho 2008;66:1127-32.
20.	McDowell TY, Amr S, Langenberg P, Royal W, Bever C, Culpepper WJ, et al. Time of birth, residential solar radiation and age at onset of multiple sclerosis. Neuroepidemiology 2010;34:238-44.
21.	Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009;73:2107-11.
22.	Sadovnick AD, Duquette P, Herrera B, Yee IM, Ebers GC. A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology 2007;69:60-2.

Advanced Biomedical Research